Advanced Search

 

Study ID Status Title Patient Level Data
29060/02/001 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/002 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/003 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/02/004 Completed A Double-Blind, Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/001 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/002 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/003 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients
29060/03/004 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/005 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/03/006 Completed A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients Study Listed on ClinicalStudyDataRequest.com
29060/057 Completed A Double-blind comparative multicentre study of paroxetine plus supportive psychotherapy and psychotherapy alone in the prevention of recurrent suicidal behavior and episodes of intermittent brief depression Study Listed on ClinicalStudyDataRequest.com
29060/07/001 Completed A Double-Blind Comparison of Paroxetine, Amitriptyline, and Placebo in Inpatients with Major Depressive Disorder with Melancholia Study Listed on ClinicalStudyDataRequest.com
29060/106 Completed A double-blind comparative study of paroxetine and placebo in the treatment of episodes of intermittent brief depression (IBD) Study Listed on ClinicalStudyDataRequest.com
29060/115 Completed A multicenter, randomized, double-blind, placebo-controlled comparison of paroxetine and fluoxetine in the treatment of major depressive disorder. Study Listed on ClinicalStudyDataRequest.com
29060/128 Completed A Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Paroxetine and Fluoxetine in the Treatment of Major Depressive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/251 Completed A Double-Blind, Randomized Trial of Paroxetine Versus Placebo In Patients With Depression Accompanied by Anxiety Study Listed on ClinicalStudyDataRequest.com
29060/276 Completed A double-blind study to investigate the efficacy, safety and tolerability of Paroxetine in the treatment of depression in comparison with placebo Study Listed on ClinicalStudyDataRequest.com
29060/282 Completed A trial to assess the effectiveness and tolerance of paroxetine by double-blind comparison with placebo using a novel “shifted crossover” design Study Listed on ClinicalStudyDataRequest.com
29060/298 Completed A double-blind study comparing the efficacy and tolerability of paroxetine and placebo in hospital out-patients with depressive symptoms associated with chronic back pain.
29060/327 Completed A double-blind, placebo-controlled, parallel group study of paroxetine in the treatment of dysthymia. Study Listed on ClinicalStudyDataRequest.com
29060/329 Completed A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Acute Phase Study Listed on ClinicalStudyDataRequest.com
29060/329_1 Completed A Multi-center, Double-blind, Placebo-Controlled Study of Paroxetine and Imipramine in Adolescents with Unipolar Major Depression - Continuation Phase. Study Listed on ClinicalStudyDataRequest.com
29060/377 Completed A Double-blind, Multicentre Placebo-Controlled Study of Paroxetine in Adolescents with Unipolar Major Depression. Study Listed on ClinicalStudyDataRequest.com
29060/448 Completed A Double-Blind, Placebo Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Modified Release Paroxetine in the Treatment of Major Depression Study Listed on ClinicalStudyDataRequest.com
29060/449 Completed A Double-Blind, Placebo Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Modified Release Paroxetine in the Treatment of Major Depression Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.